首页> 外文期刊>Morbidity and Mortality Weekly Report: CDC Surveillance Summaries >Surveillance to Track Progress Toward Polio Eradication a?? Worldwide, 2017a??2018
【24h】

Surveillance to Track Progress Toward Polio Eradication a?? Worldwide, 2017a??2018

机译:监测以追踪消灭脊髓灰质炎进展情况?全球,2017a ?? 2018

获取原文
           

摘要

When the Global Polio Eradication Initiative (GPEI) began in 1988, cases of poliomyelitis were reported from 125 countries. Since then, only Afghanistan, Nigeria, and Pakistan have experienced uninterrupted transmission of wild poliovirus (WPV). The primary means of detecting poliovirus is through surveillance for acute flaccid paralysis (AFP) among children aged <15 years with testing of stool specimens for WPV and vaccine-derived polioviruses (VDPVs) in World Health Organization (WHO)–accredited laboratories of the Global Polio Laboratory Network (GPLN) (1,2). AFP surveillance is supplemented by environmental surveillance for polioviruses in sewage at selected locations. Analysis of genomic sequences of isolated polioviruses enables assessment of transmission by time and place, potential gaps in surveillance, and emergence of VDPVs (3). This report presents 2017–2018 poliovirus surveillance data, focusing on 31 countries* identified as high-priority countries because of a “high risk of poliovirus transmission and limited capacity to adequately address those risks” (4). Some of these countries are located within WHO regions with endemic polio, and others are in regions that are polio-free. In 2018, 26 (84%) of the 31 countries met AFP surveillance indicators nationally; however, subnational variation in surveillance performance was substantial. Surveillance systems need continued strengthening through monitoring, supervision, and improvements in specimen collection and transport to provide sufficient evidence for interruption of poliovirus circulation.
机译:1988年全球根除脊髓灰质炎行动(GPEI)开始时,有125个国家报告了脊髓灰质炎病例。从那时起,只有阿富汗,尼日利亚和巴基斯坦经历了野生脊髓灰质炎病毒(WPV)的不间断传播。检测脊髓灰质炎病毒的主要手段是通过监测<15岁儿童的急性弛缓性麻痹(AFP),并在世界卫生组织(WHO)认可的全球实验室中检测粪便标本中的WPV和疫苗衍生的脊髓灰质炎病毒(VDPV)脊髓灰质炎实验室网络(GPLN)(1,2)。在特定地点对污水中的脊髓灰质炎病毒进行环境监测,以补充法新社监测。对分离的脊髓灰质炎病毒的基因组序列进行分析,可以按时间和地点评估传播情况,监测中的潜在差距以及VDPV的出现(3)。本报告提供了2017-2018年脊髓灰质炎病毒监测数据,重点关注31个国家*,这些国家由于“脊髓灰质炎病毒传播的高风险和充分应对这些风险的能力有限”而被确定为高度优先国家(4)。其中一些国家位于世卫组织流行脊髓灰质炎地区,而其他国家则位于无脊髓灰质炎地区。 2018年,在31个国家中,有26个(84%)达到了全国AFP监测指标;但是,国家以下各级的监督绩效差异很大。监视系统需要通过监视,监督以及对标本收集和运输的改进来继续加强,以提供足够的证据来阻断脊髓灰质炎病毒的流通。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号